ArticleMedicina (Kaunas, Lithuania)2026
Erythrocyte Transfusion as an Independent Predictor of Survival but Not Immune-Related Toxicity in Nivolumab-Treated Metastatic NSCLC: A Multicenter Cohort.
Mehmet Cem Fidan, Ebru Çiçek, Hamza Abbasov, Murad Guliyev, Emir Çerme, Kübra Akkaya, Bekir Doğan, Nargiz Majidova, Burak Paçacı, Ezgi Türkoğlu and 6 more
Abstract readMulticenter Study
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Mehmet Cem FidanDivision of Medical Oncology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Türkiye.ORCID 0009-0008-8199-4153 Ebru ÇiçekDivision of Medical Oncology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Türkiye.
Hamza AbbasovDivision of Medical Oncology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Türkiye.ORCID 0000-0003-1227-9996 Murad GuliyevDivision of Medical Oncology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Türkiye.ORCID 0000-0002-2981-8098 Emir ÇermeDivision of Medical Oncology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Türkiye.ORCID 0000-0002-8263-0692 Kübra AkkayaDepartment of Medical Oncology, Prof. Dr. Cemil Tascıoglu City Hospital, University of Health Sciences, Istanbul 34360, Türkiye.ORCID 0000-0001-5851-0239 Bekir DoğanDepartment of Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul 34147, Türkiye.
Nargiz MajidovaDepartment of Medical Oncology, VM Medical Park Maltepe Hospital, Istanbul 34846, Türkiye.ORCID 0000-0002-2575-5819 Burak PaçacıDivision of Medical Oncology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul 34899, Türkiye.
Ezgi TürkoğluDepartment of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Health Science University, Istanbul 34865, Türkiye.ORCID 0000-0003-3846-7047 Merve Ekinci FidanDepartment of Thoracic Surgery, Yedikule Chest Diseases and Thoracic Surgery Education and Research Hospital, Istanbul 34025, Türkiye.ORCID 0000-0002-4507-5925 Emir ÇelikDepartment of Medical Oncology, Faculty of Medicine, Topkapi Liv Hospital, Istinye University, Istanbul 34010, Türkiye.
Mesut YılmazDepartment of Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul 34147, Türkiye.ORCID 0000-0003-1466-3887 İbrahim Vedat BayoğluDivision of Medical Oncology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul 34899, Türkiye.
Özkan AlanDivision of Medical Oncology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Türkiye.
Nebi Serkan DemirciDivision of Medical Oncology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Türkiye.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, Non-Small-Cell LungErythrocyte TransfusionLung NeoplasmsNivolumabAgedAged, 80 and overAntineoplastic Agents, ImmunologicalCohort StudiesFemaleHumansKaplan-Meier EstimateMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesAntineoplastic Agents, ImmunologicalNivolumabblood transfusionimmunotherapynivolumabnon-small cell lung cancersurvivaltransfusion-related immunomodulation
Identifiers
PMID42654498
PMCPMC13515754
What OpenQuestion holds
Textmetadata
Read underepoch 390